Delivery Order SPE2DB20D3505-SPE2DB24FV0U6
Award Date
9/24/24
Potential Completion Date
9/25/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, a firm fixed price delivery order contract for HUMIRA(CF) 40 MG/0.4 ML syringes. The $1,847.20 contract has a completion date of February 13, 2024 and does not utilize any set-aside designations. This delivery order is issued under an indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,495.32, is for the delivery of HUMIRA(CF) 40 MG/0.4 ML syringes. This is a firm fixed-price delivery order contract with an ultimate completion date of April 25, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of HUMIRA (CF) 40 MG/0.4 ML syringes. The $3,616.05 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of September 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,887.42 firm fixed-price delivery order is for the supply of HUMIRA(CF) 40 MG/0.4 ML syringes. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $7,533.23 firm fixed price delivery order is for the supply of HUMIRA(CF) 40 MG/0.4 ML syringes. This award is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA Troop Support Medical, with a potential value of $999,999,999.00, to provide pharmaceutical...
This is a $2,948.67 firm fixed-price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of HUMIRA 40 MG/0.8 ML syringes to support military healthcare programs. The contract has a completion date of July 10, 2024 and was awarded on July 9, 2024. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS medication. The $11,373.24 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of October 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,316.68 firm-fixed-price delivery order contract is for the supply of HUMIRA(CF) 40 MG/0.4 ML syringes. The contract has an ultimate completion date of March 13, 2025 and was awarded on March 12, 2025. This award is associated with a larger DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of HUMIRA(CF) 40 MG/0.4 ML syringes. The contract has a ceiling value of $1,354.57 and is set to expire on April 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) 40 MG/0.4 ML syringes. The $3,523.32 firm fixed-price contract has an ultimate completion date of August 23, 2021 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...